Cristbal Morales, an endocrinologist at Virgen Macarena University Hospital in Seville, points out that, now, in the announcements that companies make to investors [for new drugs], it seems that the emphasis is on weight loss, when what we really need to focus on is healthy weight loss and maintaining muscle mass. For the specialist, the key is not to rush, but to monitor weight loss and maintain it. Despite the importance of exercise and good nutrition, which also benefits healthy people or those suffering from conditions other than obesity, doctors remind us of their limitations
Key Highlights: GLP-1 Side Effects GLP-1 side effects include both common digestive symptoms and rare but serious medical risks
Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial
Although the human body can produce glutathione on its own, production can have difficulty keeping up in times of excess stress, immune challenges, unhealthy microbial environments, or during aging, as glutathione status can decline with the natural aging process
Key Points Tirzepatide works on two hormone pathways (GLP-1 and GIP) while semaglutide targets one pathway (GLP-1) that reduces appetite and controls blood sugar levels In a direct comparison, tirzepatide helped people lose more weight, on average Both medications require weekly injections and have similar side effects, like nausea and digestive issues Additionally, semaglutide has FDA approval for heart protection benefits, while tirzepatide is approved for sleep apnea treatment Both tirzepatide (Mounjaro, Zepbound) and semaglutide (Ozempic, Wegovy) are transforming how doctors treat type 2 diabetes and obesity, but they're not identical medications
This leads to enhanced absorption of glucose by cells
